Lonza Group AG Sustainability Reports
Lonza Group AG operates as a contract development and manufacturing organization (CDMO) that provides services and products to the pharmaceutical, biotech, and nutrition industries. The company specializes in the development and scalable manufacture of active pharmaceutical ingredients, biologics, and cell or gene therapies.
Sector: Manufacturing
Country: Switzerland
Exchange: SIX Swiss Exchange
ISIN: CH0013841017
26 reports from 2006 to 2025